Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Clinical outcomes of extracranial carotid artery-related stroke eligible for mechanical reperfusion on top of per-guidelines thrombolytic therapy : analysis from a 6-month consecutive patient sample in 2 centers

Tytuł:
Clinical outcomes of extracranial carotid artery-related stroke eligible for mechanical reperfusion on top of per-guidelines thrombolytic therapy : analysis from a 6-month consecutive patient sample in 2 centers
Autorzy:
Urbańczyk-Zawadzka, Małgorzata
Grunwald, Iris Q.
Knapik, Magdalena
Stefaniak, Justyna
Koźmik, Teresa
Tekieli, Łukasz
Mazurek, Adam
Wiewiórka, Łukasz
Nizankowski, Rafał T.
Kowalczyk, Tomasz
Węglarz, Ewa
Musiałek, Piotr
Banyś, Paweł
Dzierwa, Karolina
Klecha, Artur
Data publikacji:
2022
Słowa kluczowe:
Mechanical Thrombolysis
80 and over
Common
Stroke
reperfusio
Thrombectomy
carotid stenosis
Middle Aged
female
ischemic stroke
stents
adult
Carotid Artery
Aged
male
Thrombolytic Therapy
endovascular procedures
humumans
Język:
angielski
ISBN, ISSN:
12341010
Prawa:
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
Linki:
https://medscimonit.com/abstract/full/idArt/938549  Link otwiera się w nowym oknie
Dostawca treści:
Repozytorium Uniwersytetu Jagiellońskiego
Artykuł
BACKGROUND: Systemic intravenous thrombolysis and mechanical thrombectomy (MT) are guideline-recommended reperfusion therapies in large-vessel-occlusion ischemic stroke. However, for acute ischemic stroke of extracranial carotid artery origin (AIS-CA) there have been no specific trials, resulting in a data gap. MATERIAL AND METHODS: We evaluated referral/treatment pathways, serial imaging, and neurologic 90-day outcomes in consecutive patients, presenting in a real-life series in 2 stroke centers over a period of 6 months, with AIS-CA eligible for emergency mechanical reperfusion (EMR) on top of thrombolysis as per guideline criteria. RESULTS: Of 30 EMR-eligible patients (33.3% in-window for thrombolysis and thrombolysed, 73.3% male, age 39-87 years, median Alberta Stroke Program Early Computed Tomography Score (ASPECTS) 10, pre-stroke mRS 0-1 in all, tandem lesions 26.7%), 20 (66.7%) were EMR-referred (60% – endovascular, 6.7% – surgery referrals). Only 40% received EMR, nearly exclusively in stroke centers with carotid artery stenting (CAS) expertise (100% eligible patient acceptance rate, 100% treatment delivery involving CAS±MT with culprit lesion sequestration using micronet-covered stents). The emergency surgery rate was 0%. Baseline clinical and imaging characteristics did not differ between EMR-treated and EMR-untreated patients. Ninety-day neurologic status was profoundly better in EMR-treated patients: mRS 0-2 (91.7% vs 0%; P<0.001); mRS 3-5 (8.3% vs 88.9%; P<0.001), mRS 6 (0% vs 11.1%; P<0.001). CONCLUSIONS: In a real-life AIS-CA setting, the referral rate of EMR-eligible patients for EMR was low, and the treatment rate was even lower. AIS-CA revascularization was delivered predominantly in stroke thrombectomy-capable cardioangiology centers, resulting in overwhelmingly superior patient outcome. Large vessel occlusion stroke referral and management pathways should involve centers with proximal-protected CAS expertise. AIS-CA, irrespective of any thrombolysis administration, is a hyperacute cerebral emergency and EMR-eligible patients should be immediately referred for mechanical reperfusion.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies